Recommended Pages at pharmaceutical-technology.com
Going with the flow: Continuous manufacturing - Pharmaceutical Technology
pharmaceutical-technology.com — “Continuous manufacturing has been the norm in almost all manufacturing industries. The pharmaceutical industry however has so far shied away from the continuous model, instead clinging onto batch manufacturing since the beginnings of the...” View full resource at pharmaceutical-technology.com
Most Recently Shared on January 23, 2012 at 5:34 pm By:
Paul W. Thomas Health Communicator
Good overview: RT @pharma_tech: Big #pharma has so far shied away from continuous manufacturing. http://t.co/Yc0g42Jr
US health committee recommends Merck’s HPV vaccine for boys - Pharmaceutical Technology
pharmaceutical-technology.com — “A US advisory committee has recommended that boys should be vaccinated against the human papillomavirus (HPV), which has been known to cause cancer.The US Centers of Disease Control and Prevention committee voted unanimously to approve the routine...” View full resource at pharmaceutical-technology.com
Most Recently Shared on October 27, 2011 at 5:36 pm By:
US health committee recommends Merck’s HPV vaccine for boys: A US advisory committee has recommended that boys... http://t.co/TIZgeNRp
Kissei Pharmaceutical to support MN-221 development programme - Pharmaceutical Technology
pharmaceutical-technology.com — “Japan's Kissei Pharmaceutical said it will pay MediciNova $2.5m to support further clinical development of MN-221 for the treatment of acute exacerbations of asthma or chronic obstructive pulmonary disease (COPD).MN-221 is a novel, highly...” View full resource at pharmaceutical-technology.com
Most Recently Shared on October 19, 2011 at 10:31 pm By:
OrganizedWisdom COPD OW Health
Kissei Pharmaceutical to support MN-221 development programme: Japan's Kissei Pharmaceutical said it will pay Me... http://t.co/rfWxUWyd
FDA clears Merck type 2 diabetes medication - Pharmaceutical Technology
pharmaceutical-technology.com — “The US Food and Drug Administration (FDA) has approved Merck's Juvisync, a once-daily therapy for type 2 diabetes that combines glucose-lowering medication sitagliptin, the active component of Januvia, with cholesterol-lowering medication...” View full resource at pharmaceutical-technology.com
Most Recently Shared on October 12, 2011 at 10:25 pm By:
FDA clears Merck type 2 diabetes medication: The US Food and Drug Administration (FDA) has approved Merck's Juvi... http://t.co/Jgy4ezr9
